Insights into the Industry
The follow-on-biologics industry has been witnessing optimal growth in recent years and is likely to continue even in upcoming years. The growth of follow-on-biologics ’s industry size can be attributed to rising investments in research & development activities, entry of new players, product innovation, technological breakthroughs, effective allocation of resources, and growing competition among business rivals to expand its regional as well as customer base. Supportive government policies and incentives, as well as favorable laws, are projected to determine the growth of the follow-on-biologics market in foreseeable future. An increase in the spending capacity of customers with the rise in disposable income will further contribute towards follow-on-biologics 's market proceeds.
This market research report is a comprehensive overview of the events taking place in the follow-on-biologics industry and impacting its growth. Our report divides the follow-on-biologics market into various segments or categories based on products, applications, region, etc. Additionally, our research analysts have listed the key players of the global follow-on-biologics market and compared them based on metrics such as market revenue, Y-O-Y sales, shipments volume, historical data, and successful implementation of business strategies such as strategic alliances, mergers & acquisitions, joint ventures, product development, and partnerships & collaborations.
Market Research Store (MRS) published a brand new report titled “Follow-On-Biologics Market research report which is segmented by Products (Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide), by Applications (Blood disorders, Oncology diseases, Chronic and autoimmune diseases, Growth hormone deficiencies), by Key Players/Companies Hospira, Biocon, Celltrion, Merck Serono, Novartis, Teva Pharmaceutical Industries Ltd., Synthon Pharmaceuticals Inc., Biogen idec Inc., LG Life Sciences”. In 2020, the global follow-on-biologics market value was registered at XX (USD Million/Billion) and is predicted to reach XX (USD Million/Billion) at a CAGR of XX% by 2028.
Request Free SampleScope of the report
| Report Attributes | Report Details |
|---|---|
| Report Title | Follow-On-Biologics Market Research Report |
| By Products | Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide |
| By Applications | Blood disorders, Oncology diseases, Chronic and autoimmune diseases, Growth hormone deficiencies |
| By Key Players | Hospira, Biocon, Celltrion, Merck Serono, Novartis, Teva Pharmaceutical Industries Ltd., Synthon Pharmaceuticals Inc., Biogen idec Inc., LG Life Sciences |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 110 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Based on these findings, the global follow-on-biologics industry study suggests strategies to existing market participants as to how they can improve & reinforce their market position. In addition to this, the study also recommends successful market penetrating strategies for new entrants. Furthermore, follow-on-biologics industry study report has included all major manufacturers and distributors operating in the follow-on-biologics market across all major regions.
Follow-On-Biologics Market Strategic Analysis
Various analytical methods such as Porter’s Five Force Analysis, SWOT analysis, Market Share Analysis, Competitive Analysis, PESTEL Analysis, Market Attractiveness Analysis, and Value Chain Analysis have been used to analyze the market in the research report. These assessments help users of the report in examining and evaluating follow-on-biologics market on the basis of different metrics such as switching costs, economies of scale, current sales, brand loyalty, brand equity, capital investments, production rights, research & development activities, copyrights & patents, legislations, effects of promotional activities, and consumer preferences.
To Get more Insights, Request a Free Sample
The information provided in our market research report is anticipated to help the industry stakeholders in the effective decision-making process and successful business outcomes. Moreover, we have been using Ansoff Matrix to help firms analyze and plan their business growth strategies.
Additionally, our report contains a growth-share matrix that aids firms’ business decisions for prioritizing their myriad businesses. We have also included GE Nine Cell Matrix that is helpful in making strategic planning and can help firms in determining their position in the market along with analyzing their growth strategies.
Our researchers also make use of the perceptual map to demonstrate how to target consumers feel about a given brand and form perception about it. We have also included the Customer-Based Brand Equity (CBBE) Model for helping firms effectively position their brands.
Follow-On-Biologics Market Key Trends Analysis
The key factors influencing the growth of the follow-on-biologics market have been assessed in the report. Factors having a huge influence on market demand and restraining factors that impact the development of the market are both addressed rigorously & in-depth in our global market research report.
Furthermore, trends that play a key role in market’s growth are discussed comprehensively in the report. Moreover, a large number of qualitative factors or measurements are included in the report and this includes operating risks and major obstacles encountered by players in the industry.
Follow-On-Biologics Market Key Segment Analysis
The report delivers a critical assessment on the follow-on-biologics market by segmenting it based on Products, Applications, and region. All the segments and categories of the follow-on-biologics market have been evaluated based on past, present and future trends and are key parameters determining & defining the growth of the market.
The data for the market and its segments and categories are provided from 2016 to 2028. The report has identified the key segments and categories contributing substantially towards overall market growth in terms of revenue & volume.
Based on Products, the global follow-on-biologics market is segmented into Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide. Comprehensive qualitative and quantitative this segment analysis will be provided in the report from 2016 to 2028.
Based on Applications, market is divided into Blood disorders, Oncology diseases, Chronic and autoimmune diseases, Growth hormone deficiencies. A slew of business growth opportunities and dynamics affecting the different segments are analyzed and discussed in the report.
Impact Assessment of COVID-19
The COVID-19 outbreak has wreaked havoc on worldwide economic and social systems. The disease has entered several industries' value and supply chains, including the follow-on-biologics market. The government imposed lockdowns in various locations. We will examine the impact of the COVID-19 pandemic on the global market, looking at both demand and supply.
The COVID-19 pandemic's short- and long-term impacts would be explored to provide a summary. This would help build business plans for all market participants, including manufacturers, vendors, suppliers, distributors, and end-users, during and after the epidemic.
Follow-On-Biologics Market Regional Trends and Market Player’s Analysis
On the basis of region, the market is segregated into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa.
The major players holding a huge chunk of market share in the global follow-on-biologics market and impacting market profitability are evaluated after considering their product & services revenue, sales, business plans, innovations, and growth rate. The final position of a player in the market depends on market events or market happenings, new product launches, mergers & acquisitions, benchmarking, regional expansions, and technical innovations.
To Get more Insights, Request a Free Sample
For all the key stakeholders of the market, value chain and technology ecosystem, as well as the information provided in this market research report, will prove beneficial. The study offers an outline of the company’s market share and an extensive summary of the major players in the follow-on-biologics market.
Some of the leading players profiled in the global follow-on-biologics market are,
- Hospira
- Biocon
- Celltrion
- Merck Serono
- Novartis
- Teva Pharmaceutical Industries Ltd.
- Synthon Pharmaceuticals Inc.
- Biogen idec Inc.
- LG Life Sciences
The Key Audiences for Follow-On-Biologics Market Report
- Research Institutes & consulting firms
- Industry Leaders, as well as companies, aspiring to enter the follow-on-biologics market
- Student and universities
- Solution Providers, product providers, service providers, and other players in the industry
- Associated private firms and government bodies
- Individuals interested to learn about market
The report segments of the global follow-on-biologics market are as follows:
Global Follow-On-Biologics Market: By Products
- Human growth hormone
- Erythropoietin
- Monoclonal antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
- Peptide
Global Follow-On-Biologics Market: By Applications
- Blood disorders
- Oncology diseases
- Chronic and autoimmune diseases
- Growth hormone deficiencies
The Most Important Research Methodologies
Primary sources include industry experts from management corporations, processing organizations, and analytical service providers who serve businesses across the sector's value chain. We interviewed key sources to acquire qualitative and quantitative data and analyse future prospects.
Primary research undertaken for this report comprised interviews with industry professionals such as CEOs, Vice Presidents, Marketing Directors and Technology Directors of strong core organizations and institutions in major follow-on-biologics . We interviewed them to get qualitative and quantitative data.
The following are the justifications for purchasing the global Follow-On-Biologics market report:
- Statistical data is well-referenced, and the source is a significant resource for directing interested companies.
- Market development trends and marketing channels that are cutting-edge are discussed.
- The feasibility and growth rate of the market as a whole over the foreseeable future are determined.
- The competitive landscape and demographic research provide a clear picture of the current state of the market on an international scale.
- A thorough examination of development policies and plans, manufacturing processes, and costing provides a more accurate picture of import/export consumption, supply and demand, pricing, revenue, and gross margins, among other things.
- Customization is possible based on the client's requirements.
Frequently Asked Questions
- Hospira
- Biocon
- Celltrion
- Merck Serono
- Novartis
- Teva Pharmaceutical Industries Ltd.
- Synthon Pharmaceuticals Inc.
- Biogen idec Inc.
- LG Life Sciences
Table Of Content
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Follow-On-Biologics Market Share by Type (2020-2026) 1.5.2 Human growth hormone 1.5.3 Erythropoietin 1.5.4 Monoclonal antibodies 1.5.5 Insulin 1.5.6 Interferon 1.5.7 Granulocyte-Colony Stimulating Factor 1.5.8 Peptide 1.6 Market by Application 1.6.1 Global Follow-On-Biologics Market Share by Application (2020-2026) 1.6.2 Blood disorders 1.6.3 Oncology diseases 1.6.4 Chronic and autoimmune diseases 1.6.5 Growth hormone deficiencies 1.7 Follow-On-Biologics Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Follow-On-Biologics Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Follow-On-Biologics Market 3.1 Value Chain Status 3.2 Follow-On-Biologics Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Follow-On-Biologics 3.2.3 Labor Cost of Follow-On-Biologics 3.2.3.1 Labor Cost of Follow-On-Biologics Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 Hospira 4.1.1 Hospira Basic Information 4.1.2 Follow-On-Biologics Product Profiles, Application and Specification 4.1.3 Hospira Follow-On-Biologics Market Performance (2015-2020) 4.1.4 Hospira Business Overview 4.2 Biocon 4.2.1 Biocon Basic Information 4.2.2 Follow-On-Biologics Product Profiles, Application and Specification 4.2.3 Biocon Follow-On-Biologics Market Performance (2015-2020) 4.2.4 Biocon Business Overview 4.3 Celltrion 4.3.1 Celltrion Basic Information 4.3.2 Follow-On-Biologics Product Profiles, Application and Specification 4.3.3 Celltrion Follow-On-Biologics Market Performance (2015-2020) 4.3.4 Celltrion Business Overview 4.4 Merck Serono 4.4.1 Merck Serono Basic Information 4.4.2 Follow-On-Biologics Product Profiles, Application and Specification 4.4.3 Merck Serono Follow-On-Biologics Market Performance (2015-2020) 4.4.4 Merck Serono Business Overview 4.5 Novartis 4.5.1 Novartis Basic Information 4.5.2 Follow-On-Biologics Product Profiles, Application and Specification 4.5.3 Novartis Follow-On-Biologics Market Performance (2015-2020) 4.5.4 Novartis Business Overview 4.6 Teva Pharmaceutical Industries Ltd. 4.6.1 Teva Pharmaceutical Industries Ltd. Basic Information 4.6.2 Follow-On-Biologics Product Profiles, Application and Specification 4.6.3 Teva Pharmaceutical Industries Ltd. Follow-On-Biologics Market Performance (2015-2020) 4.6.4 Teva Pharmaceutical Industries Ltd. Business Overview 4.7 Synthon Pharmaceuticals, Inc. 4.7.1 Synthon Pharmaceuticals, Inc. Basic Information 4.7.2 Follow-On-Biologics Product Profiles, Application and Specification 4.7.3 Synthon Pharmaceuticals, Inc. Follow-On-Biologics Market Performance (2015-2020) 4.7.4 Synthon Pharmaceuticals, Inc. Business Overview 4.8 Biogen idec Inc. 4.8.1 Biogen idec Inc. Basic Information 4.8.2 Follow-On-Biologics Product Profiles, Application and Specification 4.8.3 Biogen idec Inc. Follow-On-Biologics Market Performance (2015-2020) 4.8.4 Biogen idec Inc. Business Overview 4.9 LG Life Sciences 4.9.1 LG Life Sciences Basic Information 4.9.2 Follow-On-Biologics Product Profiles, Application and Specification 4.9.3 LG Life Sciences Follow-On-Biologics Market Performance (2015-2020) 4.9.4 LG Life Sciences Business Overview 5 Global Follow-On-Biologics Market Analysis by Regions 5.1 Global Follow-On-Biologics Sales, Revenue and Market Share by Regions 5.1.1 Global Follow-On-Biologics Sales by Regions (2015-2020) 5.1.2 Global Follow-On-Biologics Revenue by Regions (2015-2020) 5.2 North America Follow-On-Biologics Sales and Growth Rate (2015-2020) 5.3 Europe Follow-On-Biologics Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Follow-On-Biologics Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Follow-On-Biologics Sales and Growth Rate (2015-2020) 5.6 South America Follow-On-Biologics Sales and Growth Rate (2015-2020) 6 North America Follow-On-Biologics Market Analysis by Countries 6.1 North America Follow-On-Biologics Sales, Revenue and Market Share by Countries 6.1.1 North America Follow-On-Biologics Sales by Countries (2015-2020) 6.1.2 North America Follow-On-Biologics Revenue by Countries (2015-2020) 6.1.3 North America Follow-On-Biologics Market Under COVID-19 6.2 United States Follow-On-Biologics Sales and Growth Rate (2015-2020) 6.2.1 United States Follow-On-Biologics Market Under COVID-19 6.3 Canada Follow-On-Biologics Sales and Growth Rate (2015-2020) 6.4 Mexico Follow-On-Biologics Sales and Growth Rate (2015-2020) 7 Europe Follow-On-Biologics Market Analysis by Countries 7.1 Europe Follow-On-Biologics Sales, Revenue and Market Share by Countries 7.1.1 Europe Follow-On-Biologics Sales by Countries (2015-2020) 7.1.2 Europe Follow-On-Biologics Revenue by Countries (2015-2020) 7.1.3 Europe Follow-On-Biologics Market Under COVID-19 7.2 Germany Follow-On-Biologics Sales and Growth Rate (2015-2020) 7.2.1 Germany Follow-On-Biologics Market Under COVID-19 7.3 UK Follow-On-Biologics Sales and Growth Rate (2015-2020) 7.3.1 UK Follow-On-Biologics Market Under COVID-19 7.4 France Follow-On-Biologics Sales and Growth Rate (2015-2020) 7.4.1 France Follow-On-Biologics Market Under COVID-19 7.5 Italy Follow-On-Biologics Sales and Growth Rate (2015-2020) 7.5.1 Italy Follow-On-Biologics Market Under COVID-19 7.6 Spain Follow-On-Biologics Sales and Growth Rate (2015-2020) 7.6.1 Spain Follow-On-Biologics Market Under COVID-19 7.7 Russia Follow-On-Biologics Sales and Growth Rate (2015-2020) 7.7.1 Russia Follow-On-Biologics Market Under COVID-19 8 Asia-Pacific Follow-On-Biologics Market Analysis by Countries 8.1 Asia-Pacific Follow-On-Biologics Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Follow-On-Biologics Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Follow-On-Biologics Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Follow-On-Biologics Market Under COVID-19 8.2 China Follow-On-Biologics Sales and Growth Rate (2015-2020) 8.2.1 China Follow-On-Biologics Market Under COVID-19 8.3 Japan Follow-On-Biologics Sales and Growth Rate (2015-2020) 8.3.1 Japan Follow-On-Biologics Market Under COVID-19 8.4 South Korea Follow-On-Biologics Sales and Growth Rate (2015-2020) 8.4.1 South Korea Follow-On-Biologics Market Under COVID-19 8.5 Australia Follow-On-Biologics Sales and Growth Rate (2015-2020) 8.6 India Follow-On-Biologics Sales and Growth Rate (2015-2020) 8.6.1 India Follow-On-Biologics Market Under COVID-19 8.7 Southeast Asia Follow-On-Biologics Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Follow-On-Biologics Market Under COVID-19 9 Middle East and Africa Follow-On-Biologics Market Analysis by Countries 9.1 Middle East and Africa Follow-On-Biologics Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Follow-On-Biologics Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Follow-On-Biologics Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Follow-On-Biologics Market Under COVID-19 9.2 Saudi Arabia Follow-On-Biologics Sales and Growth Rate (2015-2020) 9.3 UAE Follow-On-Biologics Sales and Growth Rate (2015-2020) 9.4 Egypt Follow-On-Biologics Sales and Growth Rate (2015-2020) 9.5 Nigeria Follow-On-Biologics Sales and Growth Rate (2015-2020) 9.6 South Africa Follow-On-Biologics Sales and Growth Rate (2015-2020) 10 South America Follow-On-Biologics Market Analysis by Countries 10.1 South America Follow-On-Biologics Sales, Revenue and Market Share by Countries 10.1.1 South America Follow-On-Biologics Sales by Countries (2015-2020) 10.1.2 South America Follow-On-Biologics Revenue by Countries (2015-2020) 10.1.3 South America Follow-On-Biologics Market Under COVID-19 10.2 Brazil Follow-On-Biologics Sales and Growth Rate (2015-2020) 10.2.1 Brazil Follow-On-Biologics Market Under COVID-19 10.3 Argentina Follow-On-Biologics Sales and Growth Rate (2015-2020) 10.4 Columbia Follow-On-Biologics Sales and Growth Rate (2015-2020) 10.5 Chile Follow-On-Biologics Sales and Growth Rate (2015-2020) 11 Global Follow-On-Biologics Market Segment by Types 11.1 Global Follow-On-Biologics Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Follow-On-Biologics Sales and Market Share by Types (2015-2020) 11.1.2 Global Follow-On-Biologics Revenue and Market Share by Types (2015-2020) 11.2 Human growth hormone Sales and Price (2015-2020) 11.3 Erythropoietin Sales and Price (2015-2020) 11.4 Monoclonal antibodies Sales and Price (2015-2020) 11.5 Insulin Sales and Price (2015-2020) 11.6 Interferon Sales and Price (2015-2020) 11.7 Granulocyte-Colony Stimulating Factor Sales and Price (2015-2020) 11.8 Peptide Sales and Price (2015-2020) 12 Global Follow-On-Biologics Market Segment by Applications 12.1 Global Follow-On-Biologics Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Follow-On-Biologics Sales and Market Share by Applications (2015-2020) 12.1.2 Global Follow-On-Biologics Revenue and Market Share by Applications (2015-2020) 12.2 Blood disorders Sales, Revenue and Growth Rate (2015-2020) 12.3 Oncology diseases Sales, Revenue and Growth Rate (2015-2020) 12.4 Chronic and autoimmune diseases Sales, Revenue and Growth Rate (2015-2020) 12.5 Growth hormone deficiencies Sales, Revenue and Growth Rate (2015-2020) 13 Follow-On-Biologics Market Forecast by Regions (2020-2026) 13.1 Global Follow-On-Biologics Sales, Revenue and Growth Rate (2020-2026) 13.2 Follow-On-Biologics Market Forecast by Regions (2020-2026) 13.2.1 North America Follow-On-Biologics Market Forecast (2020-2026) 13.2.2 Europe Follow-On-Biologics Market Forecast (2020-2026) 13.2.3 Asia-Pacific Follow-On-Biologics Market Forecast (2020-2026) 13.2.4 Middle East and Africa Follow-On-Biologics Market Forecast (2020-2026) 13.2.5 South America Follow-On-Biologics Market Forecast (2020-2026) 13.3 Follow-On-Biologics Market Forecast by Types (2020-2026) 13.4 Follow-On-Biologics Market Forecast by Applications (2020-2026) 13.5 Follow-On-Biologics Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data SourceInquiry For Buying
Follow-On-Biologics
Request Sample
Follow-On-Biologics
